How to qualify:
Submit your PO and samples by December 19, or
Ensure your project is invoiced before December 31.
Use promo code XMAS25 when ordering via email or through our online quote form.
What is included in the offer:
For 96-well format: up to 5M reads/sample for 3′ RNA-seq services and 10M reads/sample for full-length & total RNA-seq services.
For 384-well format: up to 2M reads/sample for 3′ RNA-seq services and 5M reads/sample for full-length & total RNA-seq services.
Higher read depths are possible and available at standard rates.

We offer a variety of scalable RNA-seq library preparation, sequencing and analysis services that combine full-transcriptome coverage with unmatched cost-efficiency and the shortest turnaround times on the market.
Whether you are looking to generate and analyze data from tens to thousands of samples, our next-generation RNA-seq technologies are designed to fit your research needs and your timeline.
At Alithea Genomics, we specialize in both bulk and single-cell transcriptomics, offering scalable, high-quality RNA sequencing solutions for a wide range of research needs.
Ready to get started? Tell us about your project, and we will provide a personalized quote based on your specific needs and research goals.
Unlock deeper insights from your RNA-seq data with our tailored data analysis services.
Our preliminary data analysis can be accompanied by publication-ready visualizations such as volcano plots, clustered heatmaps, and our signature barplot wheels.
The DRUG-seq platform enabled us to systematically profile compound-induced transcriptional responses at scale, generating a rich dataset that helped prioritize testable hypotheses. The team at Alithea provided outstanding technical guidance throughout, including support in developing a customized analysis pipeline tailored to our needs. The turnaround time was fast, the process seamless, and the collaboration highly productive. We would be glad to work together again.
Mikołaj Słabicki, Ph.D. Principal Investigator at the MGH Krantz Family Center for Cancer Research. Assistant Professor of Medicine at Harvard Medical School. Affiliate Faculty Member at the Broad Institute of MIT and Harvard
DRUG-seq has completely transformed how I approach and think about transcriptomic screening. It's fast, scalable, and incredibly cost-effective—perfect for profiling hundreds of compounds in parallel. In my experience, it’s one of the most powerful tools for uncovering mechanisms of action and capturing transcriptional signatures at scale. I've used DRUG-seq to profile different cells treated under time points, dose responses, combination treatments, and a variety of complex cellular models, from cardiomyocytes to organoids—and it consistently delivers high-quality, actionable data. The ability to pool samples early without compromising data quality truly makes it a game-changer.
Andrea Hadjikyriacou, Ph.D. Principal Scientist I, Novartis Biomedical Research
BRB-seq was a great way for us to multiplex large numbers of RNA samples for sequencing. We wanted a gene expression curve with a tight temporal resolution, thus, many time points for several conditions. We are very happy with the quality of the results and with the cost benefit.
Dr. Nuno Miguel Luis CNRS Researcher
BRB-seq has proven to be an excellent method for multiplexing a large array of RNA samples for sequencing. Our team sought to generate gene expression profiles to enable our research on possible neurodegeneration therapeutic targets, requiring multiple samples for various experimental conditions. The outcomes have exceeded our expectations in terms of both result quality and cost-effectiveness, leaving us thoroughly satisfied and impressed.
Dr. Emmanouil Metzakopian VP of Research and Development, bit.bio
Check out our blog posts for detailed insights into our services, or read our overview to get the big picture. Still unsure?
Try our Service Selection Tool to find the best fit for your project.
01 Sep 2025
Tarek Elmzzahi, Chun-Hsi Su, Mehrnoush Hadaddzadeh Shakiba, Doaa Hamada, DaryaMalko, Maren Koehne, Aleksej Frolov, Teisha Mason, Yuanfang Li, Rebekka Scholz, Collins Osei-Sarpong, Leonie Heyden, Jonas Schulte-Schrepping, Lorenzo Bonaguro, Kristian Haendler, Vassiliki Boussiotis, Annett Halle, Elena De Domenico, Daniel HDGray, Martin Fuhrmann, Zeinab Abdullah, Axel Kallies, Kevin Man, Marc D. Beyer. Molecular determinants of brain-resident CD8+ T cell formation and function. bioRxiv 2025.08.26.672425
Immunology
28 Aug 2025
Akisawa Satomi, Riho Saito, Tadahaya Mizuno, Hiroki Sugishita, Hideki Ukai, Shigeyuki Shichino, Masashi Yanagisawa, Kouji Matsushima, Yukiko Gotoh, Tomohiko Okazaki. Local niche-derived immunosuppressive CXCR2+ cells impair antiviral immunity. bioRxiv 2025.08.24.671975
Infectious Diseases
27 Jun 2025
Hahaut, V., Pavlinic, D., Carbone, W et al., Fast and highly sensitive full-length single-cell RNA sequencing using FLASH-seq. Nat Biotechnol 40, 1447–1451 (2022).
Biotechnology